Trimel to Report Third Quarter 2013 Results and Host Investor Call
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 10/29/13 -- Trimel Pharmaceuticals Corporation (TSX: TRL) will report its third quarter financial results for the period ended September 30, 2013 on Sunday, November 3, 2013.
Management of the Company will host a conference call to discuss these results and update investors on the status of its business on Monday, November 4, 2013, at 8:30 a.m. Eastern Standard Time. Following the discussion, Trimel executives will address inquiries from investment analysts.
To access the call live, please dial 416-340-2216 (Toronto), 1-866-223-7781 (Canada and U.S.) or 00-800-6578-9898 (International). Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.
A replay of the conference call will be available until 7:00 p.m. Eastern Standard Time on Monday, November 11, 2013 by dialing 905-694-9451 (Toronto), 1-800-408-3053 (Canada and U.S.) or 00-800-3366-3052 (International), using access code: 5944011#.
For further information regarding Trimel Pharmaceuticals Corporation, please contact Kenneth Howling, Chief Financial Officer at (416) 679-0536 or via email at .
About Trimel
Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders. A New Drug Application for CompleoTRT™, a product using Trimel's licensed bioadhesive intranasal technology, has been accepted for review by the FDA for regulatory approval in the United States. For more information, please visit .
Contacts:
Trimel Pharmaceuticals Corporation
Kenneth G. Howling
Chief Financial Officer
416 679 0536
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.10.2013 - 15:48 Uhr
Sprache: Deutsch
News-ID 1277316
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TORONTO, ONTARIO
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 108 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Trimel to Report Third Quarter 2013 Results and Host Investor Call
"
steht unter der journalistisch-redaktionellen Verantwortung von
Trimel Pharmaceuticals Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
